The White House is pushing to reduce the prices of drugs in the United States by threatening a tariff on Europe

Open the newsletter to watch the White House for free

Your guide to what the second period of Trump means to Washington, business and the world

President Donald Trump has pledged to force European countries to pay high drug prices while pressing health care companies to reduce US consumer prices by up to 80 percent.

Speaking at the White House on Monday, Trump said that his administration would punish the countries that reject “tie” Prices of medicines with the United States Or that “blackmail” pharmaceutical companies to reduce their fees.

The threat, which included the imposition of commercial sanctions on countries that are not cooperating, opens a new struggle with trading partners in the United States after Trump’s “Tahrir Day” tariff, which was imposed around the world last month.

“We will tell these countries, such as those represented by the European Union, that the game has ended, sorryand” Trump He said. “And if they want to get cute, they will not have to sell cars in the United States anymore.”

On Monday, Trump signed an executive order that the White House was “communicating with the price goals for drug manufacturers” and “intercourse” by allowing patients to buy directly from drug manufacturers.

This proposed policy focused on the brokers who installed CIGNA and CVS shares, one of the largest pharmacy allocations who negotiate prices between manufacturers and health insurance companies.

CIGNA and CVS shares decreased by 6 percent and 4.5 percent, respectively, in the afternoon trading despite the rise in stock market. “CIGNA faces the most negative risks if the United States government begins negotiating drug prices,” Morningsar said in a report on Monday afternoon.

President He wants to reduce drug prices in the United States To the lowest price available around the world. American patients have pushed much higher Drug prices Of their peers in other industrial countries.

Trump’s direction may harm American pharmaceutical companies, which have been pressured for years to maintain the American pricing system. During his first term, Trump suggested the price controls for drugs, but this was In court. Democrats also attempted to curb the costs of drugs. Analysts said on Monday that Trump’s last suggestion is facing a similar conflict.

Trump said that the price of the price for medicines in the United States means that the Americans were paying an unjustified share pharmaceutical The company’s research and development costs.

He said that the representative of the American trade and trade will be directed to the countries that “blackmail pharmaceutical companies by preventing their products unless they accept … very low amounts“.

“This means that American patients were supporting socialist health care systems effectively in Germany, throughout the European Union – they were the most difficult. They were bad,” Trump said. “What we do mainly is a tie.”

Unlike Europe, the US government -backed insurance programs cannot negotiate the prices of certain drugs with pharmaceutical companies. The Law of Reducing inflation allowed former President Joe Biden for Medical Care, the general insurance program for the elderly, to do so for the first time for some medicines.

The United States has paid about 3.2 times more branded drugs than other developed countries in 2022, according to the Rand Healthcare Research Department of the country’s health and humanitarian department.

Trump’s announcement began a battle with the pharmaceutical industry. The Biotechnology Innovation Organization, an American lobby group, said the president’s plan was closer to “importing social medicine.”

He said on Monday: “Patients and families are not a bargaining chip in a commercial war, but this is exactly what is being treated.”